[SER140]-PLP(139-151)

[SER140]-PLP(139-151) is a fragment of myelin proteolipid protein, induce experimental autoimmune encephalomyelitis (EAE).

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
[SER140]-PLP(139-151)(CAS 122018-58-0)

CAT No: R1135

CAS No:122018-58-0

Synonyms/Alias:122018-58-0;Proteolipid protein (139-151);[SER140]-PLP(139-151);PLP(139-151)TFA;AKOS024457171;NCGC00167265-01;DA-56936;SER140-PLP(139-151)?;CAS 122018-58-0;G78392;

Chemical Name:(S,Z)-3-((Z)-(((S)-1-((2S,3Z,6Z,8S,9Z,11S,12Z,14S,15Z,18Z,20S,21Z,23S,24Z,26S)-2-((1H-imidazol-5-yl)methyl)-11-((1H-indol-3-yl)methyl)-26-amino-14-(4-aminobutyl)-4,7,10,13,16,19,22,25-octahydroxy-23-(hydroxymethyl)-27-(1H-imidazol-5-yl)-8,20-diisobutyl-3

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C72H104N20O17
M.W/Mr.
1521.7
Sequence
One Letter Code:HSLGKWLGHPDKF
Three Letter Code:H-His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe-OH
Purity
≥97% (HPLC)
Length
13
Long-term Storage Conditions
Soluble to 2 mg/ml in water
Shipping Condition
Ship with RT , or blue ice upon request
InChI
InChI=1S/C72H104N20O17/c1-40(2)25-51(63(99)80-36-60(95)84-55(30-45-34-77-39-82-45)71(107)92-24-14-21-58(92)70(106)89-54(31-61(96)97)68(104)85-50(20-11-13-23-74)66(102)90-56(72(108)109)27-42-15-6-5-7-16-42)86-67(103)53(28-43-32-78-48-18-9-8-17-46(43)48)88-65(101)49(19-10-12-22-73)83-59(94)35-79-64(100)52(26-41(3)4)87-69(105)57(37-93)91-62(98)47(75)29-44-33-76-38-81-44/h5-9,15-18,32-34,38-41,47,49-58,78,93H,10-14,19-31,35-37,73-75H2,1-4H3,(H,76,81)(H,77,82)(H,79,100)(H,80,99)(H,83,94)(H,84,95)(H,85,104)(H,86,103)(H,87,105)(H,88,101)(H,89,106)(H,90,102)(H,91,98)(H,96,97)(H,108,109)/t47-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-/m0/s1
InChI Key
UQIBUOXNUPHALR-UVIWMAFZSA-N
Canonical SMILES
[H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Modification ServicesCustom Conjugation ServicecGMP Peptide ServicePeptide Analysis ServicesEpitope Mapping ServicesPeptide Synthesis ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers